Jonathan G. Zaroff, MD
Studies
Long-Term Outcome in Unruptured Brain Arteriovenous Malformation Patients
This study has three aims: 1) To identify predictors of hemorrhage and poor outcome in the untreated course of unruptured brain arteriovenous malformation patients, 2) To identify predictors of hemorrhage and poor outcome in the treated course of unruptured brain arteriovenous malformation patients, and 3) To compare five-year outcomes in untreated versus surgically-treated unruptured brain arteriovenous malformation patients.
Investigator: Zaroff, Jonathan
Funder: National Institute of Neurological Disorders and Stroke
Publications
Association Between Serum Albumin and Outcomes in Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial
Authors: Feng, Kent Y; Ambrosy, Andrew P; Zaroff, Jonathan G; COAPT trial investigators,; et al.
Eur J Heart Fail. 2023 Apr;25(4):553-561. Epub 2023-03-07.
Challenges encountered in conducting donor-based research: Lessons learned from the Donor Heart Study
Authors: Khush, Kiran K; Malinoski, Darren; Malinoski, Darren; et al.
Am J Transplant. 2022 07;22(7):1760-1765. Epub 2022-04-18.
Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
Authors: Bakker, Mark K; Zaroff, Jonathan G; Ruigrok, Ynte M; et al.
Nat Genet. 2020 12;52(12):1303-1313. Epub 2020-11-16.
Echocardiographic Outcomes after Transcatheter Leaflet Approximation in Patients with Secondary Mitral Regurgitation: The COAPT Trial
Authors: Asch FM; Zaroff JG; COAPT Investigators; et al.
J Am Coll Cardiol. 2019 12 17;74(24):2969-2979. Epub 2019-09-28.
Amyloid cardiomyopathy in a large integrated health care system
Authors: Czobor P; Hung YY; Baer D; McGlothlin D; Weisshaar D; Zaroff J
Am Heart J. 2019 10;216:42-52. Epub 2019-06-20.
Assessing the Hereditary Hemorrhagic Telangiectasia Algorithms in a Community-Based Patient Population
Authors: Saparia T; Faughnan ME; Schneider JL; Almers LM; Chow N; Grosse SD; Kim H; Zaroff JG
Perm J. 2019;23.
Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals
Authors: Marcus JL; Zaroff J; Go AS; Quesenberry CP; Lo JC; Silverberg MJ; et al.
HIV Med. 2019 01;20(1):19-26. Epub 2018-09-04.
Genome-wide association study of sporadic brain arteriovenous malformations
Authors: Weinsheimer S; Zaroff JG; GEN-AVM Consortium; et al.
J Neurol Neurosurg Psychiatr. 2016 Sep;87(9):916-23. Epub 2016-01-27.
Assessment of heart transplant waitlist time and pre- and post-transplant failure: A mixed methods approach
Authors: Goldstein BA; Thomas L; Zaroff JG; Nguyen J; Menza R; Khush KK
Epidemiology. 2016 07;27(4):469-76.
Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease
Authors: Krishnaswami A; Goh AC; Go AS; Lundstrom RJ; Zaroff J; Jang JJ; Allen E
Am J Cardiol. 2016 May 15;117(10):1596-603. Epub 2016-03-02.
Permanent Pacemaker Implantation Early After Cardiac Surgery: A Descriptive Study of Pacemaker Utility After One Year of Follow-Up
Authors: Patel AM; Verma D; Jiang SF; Lau KY; Arrellano JL; Cain BS; Zaroff JG
J Card Surg. 2016 Mar;31(3):132-8. Epub 2016-01-12.
Nonutilization of Statins in a Community-Based Population with a History of Coronary Revascularization
Authors: Peng JA; Ancock BP; Conell C; Almers LM; Chau Q; Zaroff JG
Clin Ther. 2016 Feb;38(2):288-296.e2. Epub 2015-Dec-22.
Cardiac Events After Kidney Transplantation According to Pretransplantation Coronary Artery Disease and Coronary Revascularization Status
Authors: Felix R; Saparia T; Hirose R; Almers L; Chau Q; Jonelis T; Zheng S; Zaroff J
Transplant Proc. 2016 Jan-Feb;48(1):65-73.
Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain
Authors: Kremer PH; Zaroff JG; Klijn CJ; et al.
J Neurol Neurosurg Psychiatr. 2015 May;86(5):524-9. Epub 2014-07-21.
Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms
Authors: Bendjilali N; Nelson J; Weinsheimer S; Sidney S; Zaroff JG; Hetts SW; Segal M; Pawlikowska L; McCulloch CE; Young WL; Kim H
J Neurol Neurosurg Psychiatr. 2014 Nov;85(11):1280-3. Epub 2014-04-28.
Short QT in a Cohort of 1.7 Million Persons: Prevalence, Correlates, and Prognosis
Authors: Iribarren C; Round AD; Peng JA; Lu M; Klatsky AL; Zaroff JG; Holve TJ; Prasad A; Stang P
Ann Noninvasive Electrocardiol. 2014 Sep;19(5):490-500. Epub 2014-05-14.
Long-term Cardiovascular Outcomes in Survivors of Kawasaki Disease
Authors: Holve TJ; Patel A; Chau Q; Marks AR; Meadows A; Zaroff JG
Pediatrics. 2014 Feb;133(2):e305-11. Epub 2014-01-20.
Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study
Authors: Iribarren C; Round AD; Peng JA; Lu M; Zaroff JG; Holve TJ; Prasad A; Stang P
Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1222-32. Epub 2013-07-16.
Cardiovascular Predictors of Long-Term Outcomes After Non-Traumatic Subarachnoid Hemorrhage
Authors: Zaroff JG; Leong J; Kim H; Young WL; Cullen SP; Rao VA; Sorel M; Quesenberry CP Jr; Sidney S
Neurocrit Care. 2012 Dec;17(3):374-81.
G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation
Authors: Weinsheimer S; Zaroff JG; Kim H; et al.
Transl Stroke Res. 2012 Dec;3(4):418-27. Epub 2012-08-14.
Electrocardiographic Characteristics of Potential Organ Donors and Associations with Cardiac Allograft Utilization
Authors: Khush KK; Menza R; Nguyen J; Goldstein BA; Zaroff JG; Drew BJ
Circ Heart Fail. 2012 Jul 1;5(4):475-83. Epub 2012 May 21.
Surgical candidacy and selection biases in nonemergent left main stenting implications for observational studies
Authors: McNulty EJ; Ng W; Spertus JA; Zaroff JG; Yeh RW; Ren XM; Lundstrom RJ
JACC Cardiovasc Interv. 2011 Sep;4(9):1020-7.
Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage
Authors: Taub PR; Fields JD; Wu AH; Miss JC; Lawton MT; Smith WS; Young WL; Zaroff JG; Ko NU
Neurocrit Care. 2011 Aug;15(1):13-8.
Angiopoietin-like 4 (ANGPTL4) gene polymorphisms and risk of brain arteriovenous malformations
Authors: Mikhak B; Sidney S; McCulloch CE; Kim H; et al.
Cerebrovasc Dis. 2011;31(4):338-45. Epub 2011 Jan 7.
Perioperative hypothermia (33 degrees C) does not increase the occurrence of cardiovascular events in patients undergoing cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial
Authors: Nguyen HP; Zaroff JG; Bayman EO; Gelb AW; Todd MM; Hindman BJ; IHAST-MIDS and IHAST Investigators
Anesthesiology. 2010 Aug;113(2):327-42.
Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population
Authors: Gabriel RA; Kim H; Sidney S; McCulloch CE; Singh V; Johnston SC; Ko NU; Achrol AS; Zaroff JG; Young WL
Stroke. 2010 Jan;41(1):21-6. Epub 2009 Nov 19.
Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation
Authors: Kim H; Zaroff JG; Young WL; et al.
Cerebrovasc Dis. 2009;27(2):176-82. Epub 2008 Dec 18.
Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage
Authors: Ko NU; Rajendran P; Kim H; Rutkowski M; Pawlikowska L; Kwok PY; Higashida RT; Lawton MT; Smith WS; Zaroff JG; Young WL
Stroke. 2008 Apr;39(4):1103-8. Epub 2008 Feb 28.
Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study
Authors: Marcus GM; Whooley MA; Glidden DV; Pawlikowska L; Zaroff JG; Olgin JE
Am Heart J. 2008 Feb;155(2):303-9. Epub 2007 Oct 25.
Apolipoprotein E2 Is Associated with New Hemorrhage Risk in Brain Arteriovenous Malformations
Authors: Pawlikowska L; Poon KY; Achrol AS; McCulloch CE; Ha C; Lum K; Zaroff JG; Ko NU; Johnston SC; Sidney S; Marchuk DA; Lawton MT; Kwok PY; Young WL
Neurosurgery. 2006 May 01;58(5):838-843.
Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations
Authors: Pawlikowska L; Marchuk DA; Young WL; et al.
Neurosurgery. 2006 May;58(5):838-43; discussion 838-43.
Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations
Authors: Achrol AS; Marchuk DA; UCSF BAVM Study Project; et al.
Stroke. 2006 Jan;37(1):231-4. Epub 2005 Dec 1.
